Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus vs Advagraf in de Novo Liver Transplant Recipients (EnGraft)
NCT04720326Phase 4Active, not recruiting
- Start
- Dec 2020
- Primary completion
- Jan 2024
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in Liver transplant rejection. Started Dec 2020; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT04720326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04720326.